Illinois HB4954 mandates reporting requirements for entities participating in the 340B Drug Pricing Program.
HB4954, known as the 340B Drug Pricing Program Reporting Act, requires 340B covered entities to report specified information and transactions to the Illinois Department of Public Health annually. The report includes details such as the date of service, prescription number, fill number, and the number of low-income patients served. Pharmaceutical manufacturers may request this data for compliance purposes. The Department must compile and publish an annual report, which is confidential and not available for public inspection.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.